1.
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
2.
3.
4.
5.
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis